Success Stories: Premium Processing Accelerates EB2-NIW Approval for a Biotechnology Postdoctoral Associate from India
Client’s Testimonial:
“I would like to express my deepest gratitude to the entire team at North America Immigration Law Group (NAILG) for their outstanding support and expert guidance throughout my EB2-NIW petition process. NAILG far exceeded my expectations in every regard.
From our first interaction, the team was highly organized, communicative, and deeply knowledgeable. They took the time to carefully assess my academic and research profile and provided a realistic and transparent evaluation of my case.
What I especially appreciated was how effectively NAILG translated complex scientific findings into accessible, persuasive language suitable for USCIS officers. Their legal writing was sharp, evidence-based, and strategic. The process from document collection to final petition submission was smooth, well-structured, and always on schedule.
I wholeheartedly recommend NAILG to any researcher or professional navigating the EB2-NIW process. Their team combines legal precision with a genuine commitment to their clients’ success. Choosing them was one of the best decisions I made in my immigration journey, and I am sincerely thankful for their support.”
On June 7th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Postdoctoral Associate in the Field of Biotechnology (Approval Notice).
General Field: Biotechnology
Position at the Time of Case Filing: Postdoctoral Associate
Country of Origin: India
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: June 7th, 2025
Processing Time: 1 month (Premium Processing Requested)
Case Summary:
NAILG (North America Immigration Law Group) is proud to announce the successful approval of an I-140 EB2-NIW (National Interest Waiver) petition for a postdoctoral associate from India specializing in biotechnology. When the client approached us seeking expert assistance with his petition, we conducted a thorough evaluation of his academic background and research accomplishments and recognized a strong case with excellent potential for success. We created a comprehensive petition underscoring the candidate’s significant accomplishments and supporting documentation. The petition was approved swiftly through the direct premium processing in just 1 month.
Proposed endeavor that aims to advance biotechnology and public health.
The client’s proposed endeavor centers on developing and applying advanced immunological and virological methodologies to investigate viral persistence and immune response mechanisms. By focusing on chronic diseases such as HIV and Epstein-Barr Virus (EBV), this research aims to advance therapeutic strategies and vaccine development. Client’s work has the potential to lower disease burdens significantly and improve public health outcomes in the United States, addressing critical healthcare challenges and contributing to national priorities in biotechnology and infectious disease control.
Demonstrating notable academic and professional milestones.
The client has published 8 peer-reviewed journal articles, including 5 as first author, along with 2 abstracts (1 of them first-authored) and 1 first-authored preprint in top journals, including no fewer than 3 highly ranked peer-reviewed journals. Notably, one of his articles ranks among the top 20% most cited papers in Molecular Biology & Genetics for its year of publication. Overall, his work has been cited 174 times, highlighting the significant impact and recognition of his research. Additionally, he has completed at least 12 peer reviews for respected journals, underscoring his role as a trusted expert and active contributor to the field.
Secured vital funding from prestigious institutions.
The client’s research has received funding from several prestigious organizations, highlighting the importance and impact of his work in biotechnology:
● National Institutes of Health (NIH)
● National Institute of Allergy and Infectious Diseases (NIAID)
● Department of Biotechnology, Government of India
● Moderna, Inc.
These institutions support research directed at advancing the national interest, including improving public health and developing innovative medical therapies.
Expert recommendations highlight the national importance of the research.
Two strong recommendation letters supported the petition, emphasizing the client’s significant contributions and their impact on public health and biotechnology in the United States. One leading expert remarked:
“The importance of [client’s] research is evidenced by his ingenuity in developing new techniques that have advanced our understanding of HIV reservoirs in children and thereby are informing new ways to achieve remission or cure. Ensuring that [client’s] work proceeds is thus not only important to the field but to the United States as well.”
Swift approval highlights the Strategic Petition.
NAILG’s strategic petition secured the client’s I-140 EB2-NIW approval in just 1 month via the premium processing, reflecting both his strong credentials and the vital impact of his work on U.S. health and biotechnology. We congratulate the client on this well-deserved achievement and look forward to his continued contributions.